Milestone Pharmaceuticals Inc. Share Price & Technical Analysis
MIST · $1.32 (-2.94%)
Healthcare / Biotechnology
$1.32
-2.94%
Milestone Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of cardiovascular medicines in the United States and Canada. It offers CARDAMYST (etripamil) nasal spray, a prescription medication for the conversion of acute symptomatic episodes of paroxysmal supraventricular tachycardia (PSVT) to sinus rhythm in adults. The company is also developing e…
Price chart
Seasonality
Jun has 2 positive and 3 negative years (last 5 years shown)
-7% return in Jun, -8% avg return in past 3 year Jun month.
-24% return in 2026, 4% avg return in past 3 years.
Swipe sideways to see all months →
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Yr | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 | -5% | -11% | -29% | 50% | -22% | -7% | – | – | – | – | – | – | -24% |
| 25 | -17% | -20% | -56% | 63% | 23% | 19% | -25% | 29% | 11% | -5% | 35% | -26% | 31% |
| 24 | 0% | 6% | 6% | -11% | -6% | -13% | 0% | -7% | 7% | 0% | 33% | 20% | 35% |
| 23 | -7% | -14% | 22% | -10% | 8% | -28% | 14% | -16% | 11% | -13% | 27% | -48% | -55% |
| 22 | 5% | -29% | 28% | 5% | -16% | 11% | 21% | 18% | 6% | -46% | -2% | -17% | -18% |
Monthly return % by calendar month · historical pattern, not a forecast
Bearish · Downtrend · Weak
Milestone Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of cardiovascular medicines in the United States and Canada. It offers CARDAMYST (etripamil) nasal spray, a prescription medication for the conversion of acute symptomatic episodes of paroxysmal supraventricular tachycardia (PSVT) to sinus rhythm in adults. The company is also developing etripamil for the indication of atrial fibrillation with rapid ventricular rate (AFib-RVR). It has a license and collaboration agreement with Corxel Pharmaceuticals to develop and commercialize etripamil. Milestone Pharmaceuticals Inc.was incorporated in 2003 and is headquartered in Montreal, Canada.
Full AI Q&A, portfolio tracking, and live alerts in the app.
Key metrics
Market cap
$165.59M
P/E ratio
—
52W high
$3.06
52W low
$1.00
Volume
11,93,255
Beta
1.04
Related stocks in Healthcare
Merck & Co Inc Cedear (5…
₹34,400
Abbott Laboratories Cede…
₹32,740
Eli Lilly And Company Ce…
₹28,720
Unitedhealth Group Inc C…
₹17,140
Elevance Health Inc
₹6,770
Frequently asked questions
- What is Milestone Pharmaceuticals Inc. share price today?
- Milestone Pharmaceuticals Inc. (MIST) last traded around $1.32 on StockPro. Prices refresh every few minutes during market hours.
- What technical signals does MIST have?
- StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for MIST. Download the app for real-time alerts.
- How can I analyze Milestone Pharmaceuticals Inc. stock?
- Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.